- Correction
- Open access
- Published:
Correction: A meta‑analysis of colchicine in prevention of atrial fibrillation following cardiothoracic surgery or cardiac intervention
Journal of Cardiothoracic Surgery volume 17, Article number: 285 (2022)
The Original Article was published on 01 September 2022
Correction: Journal of Cardiothoracic Surgery (2022) 17:224 https://doi.org/10.1186/s13019-022-01958-9.
Following publication of the original article [1], the author would like to change the Result and conclusion section in abstract part
from
Results: A total of 9 RCTs were included in this meta-analysis, enrolling a total of 2031 patients. Colchicine significantly reduces the incidence of POAF (RR 0.62; 95% CI, 0.52–0.74, P < 0.001, I2 = 0%). Subgroup analyses indicated that the protective effect of colchicine on POAF was slightly stronger in the long-duration group (RR 0.60; 95% CI, 0.48–0.75, P < 0.001, I2 = 0%) than in the short-duration group (RR 0.65; 95% CI, 0.49–0.86, P < 0.001, I2 = 0%).
Conclusion: Colchicine is effective in preventing the occurrence of POAF. The efficacy of colchicine can be slightly increased over treatment duration, with no obvious adverse reactions.
to.
Results: A total of 9 RCTs were included in this meta-analysis, enrolling a total of 2031 patients. Colchicine significantly reduces the incidence of POAF (RR 0.62; 95% CI, 0.52–0.74, P < 0.001, I2 = 0%). Subgroup analyses indicated that the protective effect of colchicine on POAF was almost the same (P = 0.71) in the long-duration group (RR 0.60; 95% CI, 0.48–0.75, P < 0.001, I2 = 0%) and the short-duration group (RR 0.65; 95% CI, 0.49–0.86, P < 0.001, I2 = 0%).
Conclusion: Colchicine is effective in preventing the occurrence of POAF. The efficacy of colchicine cannot be increased over treatment duration, with no obvious adverse reactions.
The original article has been corrected.
Reference
Zhao V, et al. J Cardiothorac Surg. 2022;17:224. https://doi.org/10.1186/s13019-022-01958-9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhao, H., Chen, Y., Mao, M. et al. Correction: A meta‑analysis of colchicine in prevention of atrial fibrillation following cardiothoracic surgery or cardiac intervention. J Cardiothorac Surg 17, 285 (2022). https://doi.org/10.1186/s13019-022-02030-2
Accepted:
Published:
DOI: https://doi.org/10.1186/s13019-022-02030-2